Molecular Targeted Agents Combined with Chemo-Radiation in the Treatment of Locally Advanced Cervix Cancer
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
111-120
Author(s):
F. G. Herrera, L. Vidal, A. Oza, M. Milosevic and A. Fyles
Immunotherapy of Pancreatic Carcinoma
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
121-125
Author(s):
Angela Marten
Promoter Structure and Transcriptional Regulation of Human β-Galactoside α2, 3-Sialyltransferase Genes
Journal:
Current Drug Targets
Volume:
9
Page:
310-316
Author(s):
Akiyoshi Taniguchi
Molecular Targets and Targeted Therapies for Malignant Mesothelioma
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
855-867
Author(s):
Camilla Palumbo, Roberto Bei, Antonio Procopio and Andrea Modesti
ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
978-990
Author(s):
R. Schmidmaier and P. Baumann
AGE-RAGE System and Carcinogenesis
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
940-945
Author(s):
Riichiro Abe and Sho-ichi Yamagishi
Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner]
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1048-1048
Author(s):
Elke Bergmann-Leitner
Arginine Deprivation as a Targeted Therapy for Cancer
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1049-1057
Author(s):
L. Feun, M. You, C. J. Wu, M. T. Kuo, M. Wangpaichitr, S. Spector and N. Savaraj
Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1058-1077
Author(s):
Snezana K. Bjelogrlic, Sinisa Radulovic and Nada Babovic
Combinatorial Application of Nucleic Acid-Based Agents Targeting Protein Kinases for Cancer Treatment
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1098-1112
Author(s):
B. Spankuch and K. Strebhardt